Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination
- PMID: 34049360
- DOI: 10.1097/TP.0000000000003836
Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination
Conflict of interest statement
The authors declare no funding or conflicts of interest.
Comment on
-
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385. JAMA. 2021. PMID: 33720292 Free PMC article.
-
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489. JAMA. 2021. PMID: 33950155 Free PMC article.
References
-
- Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021;325:1784–1786.
-
- Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206.
-
- Zervou F, Ali N, Neumann H, et al. COVID-19 antibody tesponses in solid organ transplant recipients. 2020;7(suppl 1):S332.
-
- Benotmane I, Gautier-Vargas G, Wendling MJ, et al. In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020;20:3162–3172.
-
- Boyarsky BJ, Ou MT, Werbel WA, et al. Early development and durability of SARS-CoV-2 antibodies among solid organ transplant recipients: a pilot study. Transplantation. 2021;105:e52–e53.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous